impetigo: A pyoderma consisting of three forms of skin lesions having either a thick, adherent, recurrent, dirty yellow crust with an erythematous margin (common or superficial impetigo) or lessions which are superficial, thin-walled, and bullous as found in bullous impetigo. The lesions in bullous (staphylococcal) impetigo, which are always caused by S aureus, are superficial, thin-walled, and bullous.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1787 |
4. Check minimum number of eventsNone |
1787 |
5. Include endpointsNone |
1787 |
6. Filter based on genotype QC (FinnGen only) |
1787 |
Control definitions (FinnGen only)
- Control exclude
- L12_INFECT_SKIN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L00-L08
- Name in latin
- Impetigo
Similar endpoints
↥List of similar endpoints to
Impetigo
based on the number of shared cases.
Similar with more cases:
- Infections of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 28301 | 13366 | 14843 |
| Only index persons | 20231 | 9754 | 10477 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.40 | 0.38 | 0.41 |
| Only index persons | 0.38 | 0.36 | 0.40 |
| Median age at first event (years) | |||
| Whole population | 10.66 | 11.12 | 10.05 |
| Only index persons | 15.69 | 15.96 | 15.43 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1787 | 1033 | 754 |
| Unadjusted period prevalence (%) | 0.34 | 0.35 | 0.33 |
| Median age at first event (years) | 23.24 | 24.08 | 22.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1601
- Matched controls
- 16011
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
168.4
323.0
739
81
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
248.7
302.9
303
15
68409
ICD-8 Finland
Impetigo, Unspecified
+∞
200.3
188
*
68408
ICD-8 Finland
Impetigo, Alia definita
+∞
181.8
171
*
6840A
ICD-9 Finland
Impetigo[IMPETIGO CONTAGIOSA]
+∞
115.0
109
*
L20.0
ICD-10 Finland
Besnier prurigo
4.9
93.8
347
856
E0000UV
ATC
NA
2.9
87.4
833
4349
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
20.6
81.9
124
65
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.7
70.2
349
1110
L01
ICD-10 Finland
Impetigo
12.5
68.2
126
109
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.7
66.2
331
1052
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.2
62.3
388
1452
D07AC01
ATC
betamethasone; topical
2.6
58.8
596
3011
E000001
ATC
NA
2.8
57.3
467
2073
D07AA02
ATC
hydrocortisone; topical
3.0
55.2
383
1529
D07AB08
ATC
desonide; topical
3.6
53.8
269
843
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
10.0
51.0
105
112
J01DB01
ATC
cefalexin; oral
2.6
47.9
1343
10717
E000002
ATC
NA
3.0
45.7
294
1100
J01FF01
ATC
clindamycin; systemic
2.4
41.8
440
2187
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
41.6
482
2512
D07CC01
ATC
betamethasone and antibiotics; topical
3.0
41.6
270
1013
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.9
40.4
285
1127
TQW80
NOMESCO Finland
Local dermatologic skincare
8.2
39.7
91
117
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
14.2
39.1
67
49
D07AC13
ATC
mometasone; topical
2.2
37.7
476
2563
N05BB01
ATC
hydroxyzine; systemic
3.8
37.0
167
474
A46
ICD-10 Finland
Erysipelas
3.3
35.7
198
660
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
4.6
34.5
126
293
D11AH01
ATC
tacrolimus; topical
10.0
34.0
69
72
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
33.0
165
509
H02AB06
ATC
prednisolone; systemic
1.9
31.3
668
4369
R06AE07
ATC
cetirizine; oral
1.9
30.9
732
4961
L30.3
ICD-10 Finland
Infective dermatitis
5.2
29.8
95
191
70708
ICD-8 Finland
Chronic ulcer of skin, Aliud definitum
+∞
29.2
28
*
E000003
ATC
NA
3.9
28.4
124
341
D11AX14
ATC
[U] tacrolimus; topical
24.1
28.4
40
17
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
28.4
211
851
J01DA01
ATC
[U] cefalexin; systemic
1.8
28.2
939
7045
D07BC01
ATC
betamethasone and antiseptics; topical
2.7
27.7
203
810
XQ802
NOMESCO Finland
Epicutan test
4.3
27.6
106
259
J05AB01
ATC
aciclovir; systemic
2.2
26.9
324
1671
E000006
ATC
NA
3.3
26.8
145
473
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
7.4
26.7
64
89
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.0
26.0
440
2601
D02AE01
ATC
carbamide; topical
3.2
26.0
145
482
L08.0
ICD-10 Finland
Pyoderma
13.2
25.7
45
35
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.6
23.8
193
814
D07AD01
ATC
clobetasol; topical
2.3
21.3
220
1046
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
20.9
543
3655
H03.8*L01.0
ICD-10 Finland
Involvement of eyelid in impetigo
+∞
20.9
20
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
20.4
183
812
R06AX27
ATC
desloratadine; oral
1.8
20.3
487
3193
XQ800
NOMESCO Finland
Prick test
2.4
20.1
175
765
D02AX
ATC
Other emollients and protectives
3.2
19.4
104
338
L20
ICD-10 Finland
Atopic dermatitis
3.6
19.2
90
263
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
18.7
298
1693
S87
ICPC
Dermatitis/atopic eczema
4.0
18.7
76
197
D11AH02
ATC
pimecrolimus; topical
12.5
18.1
32
26
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
7.5
18.0
42
57
XQ848
NOMESCO Finland
Dermatological photography
4.9
17.1
56
118
S29
ICPC
Skin symptom/complaint other
1.9
16.4
250
1394
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
5.8
16.4
46
81
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
16.2
268
1536
D09AB01
ATC
zinc bandage without supplements; topical
5.3
15.9
48
92
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.0
15.9
51
105
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
15.9
148
667
B00.10
ICD-10 Finland
Herpes simplex facialis
9.3
15.7
32
35
68400
ICD-8 Finland
Impetigo, Pemphigus neonatorum
+∞
15.6
15
*
E000004
ATC
NA
5.6
15.6
45
82
J05AB11
ATC
valaciclovir; oral
2.1
15.4
182
915
D07XB05
ATC
dexamethasone, combinations; topical
4.5
15.0
53
121
E000007
ATC
NA
2.5
14.7
116
481
H02AB07
ATC
prednisone; oral
2.1
14.6
177
899
H02AB04
ATC
methylprednisolone; systemic
2.0
14.2
190
1006
S76
ICPC
Skin infection other
3.0
14.0
82
285
L30.0
ICD-10 Finland
Nummular dermatitis
3.8
13.8
58
157
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
75.8
13.6
15
*
395
Kela drug reimbursment
Dupilumab
+∞
13.6
13
*
J01MA12
ATC
levofloxacin; systemic
1.9
13.6
206
1144
S01AD03
ATC
aciclovir; ophthalmic
3.3
13.2
65
200
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
13.0
173
912
D07XC01
ATC
betamethasone, combinations; topical
2.1
12.9
160
819
L03.2
ICD-10 Finland
Cellulitis of face
19.2
12.9
19
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
12.7
303
1948
N06AX16
ATC
venlafaxine; oral
1.8
12.6
218
1262
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.8
12.6
52
139
D11AH05
ATC
dupilumab; topical
+∞
12.5
12
*
R06AE09
ATC
levocetirizine; oral
1.8
12.5
242
1460
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
12.5
788
6366
R50.9
ICD-10 Finland
Fever, unspecified
1.8
12.4
221
1294
R03AC02
ATC
salbutamol; inhalant
1.5
12.4
776
6253
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.3
12.3
117
532
L04AD01
ATC
ciclosporin; systemic
4.3
12.3
45
108
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
12.2
89
354
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
11.9
124
589
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
4.1
11.8
45
112
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.4
11.8
103
449
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
11.7
242
1485
L27.2
ICD-10 Finland
Dermatitis due to ingested food
3.6
11.7
51
143
C01CA24
ATC
epinephrine; parenteral
2.2
11.6
122
582
D11AX15
ATC
[U] pimecrolimus; topical
23.1
11.6
16
7
M79.6
ICD-10 Finland
Pain in limb
1.5
11.5
450
3267
SPAT1263
SPAT
Sampling
1.5
11.4
618
4807
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.4
11.4
33
62
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.1
11.3
43
107
N02AX02
ATC
tramadol; systemic, rectal
1.5
11.3
472
3476
R51.80
ICD-10 Finland
Headache
1.7
11.2
242
1503
S97
ICPC
Chronic ulcer skin
3.2
11.2
59
192
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
11.2
320
2152
Z71.8
ICD-10 Finland
Other specified counselling
1.6
11.0
358
2486
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
12.0
10.8
19
16
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
10.8
103
472
S06.0
ICD-10 Finland
Concussion
1.9
10.8
162
893
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
10.8
72
273
49300
ICD-8 Finland
Asthma, bronchiale
4.3
10.8
39
93
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
7.2
10.8
25
35
N05AH04
ATC
quetiapine; oral
1.7
10.7
257
1649
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
10.7
109
516
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
10.6
773
6339
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.6
135
703
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
10.5
245
1557
L04AX01
ATC
azathioprine; systemic
2.6
10.5
75
297
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
10.4
250
1599
S84
ICPC
Impetigo
5.7
10.4
29
52
N06AB04
ATC
citalopram; systemic
1.6
10.4
260
1685
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.6
10.3
29
53
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
7.5
10.2
23
31
WW200
NOMESCO Finland
Immunization
3.1
10.1
53
173
S18
ICPC
Laceration/cut
1.5
10.1
481
3626
N05BA01
ATC
diazepam; systemic, rectal
1.8
10.0
161
914
J01CF05
ATC
flucloxacillin; systemic
2.9
9.9
58
204
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
5.7
9.8
27
48
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
9.7
278
1864
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
9.7
299
2041
P01AB01
ATC
metronidazole; oral, rectal
1.5
9.6
472
3567
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.6
318
2206
WZC30
NOMESCO Finland
Teaching
1.9
9.6
154
870
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
9.6
500
3829
N02AA05
ATC
oxycodone; systemic
1.9
9.4
134
728
H62.4*L01.0
ICD-10 Finland
Otitis externa in impetigo
+∞
9.4
9
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.4
9.4
27
51
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
9.3
255
1690
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
9.3
174
1036
134
Kela drug reimbursment
General erythroderma
13.7
9.2
15
11
SPAT1153
SPAT
Removal of sutures
1.5
9.1
346
2475
S21
ICPC
Skin texture symptom/complaint
1.8
9.1
159
925
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
9.1
179
1082
L04AA06
ATC
mycophenolic acid; systemic
4.1
9.1
34
85
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
9.0
213
1357
R06AX13
ATC
loratadine; oral
1.6
9.0
228
1481
127
Kela drug reimbursment
Transplant complication
4.1
8.9
33
82
ZX112
NOMESCO Finland
Subcutaneous
3.7
8.7
37
103
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
8.7
224
1460
WX002
NOMESCO Finland
Sedation and analgesia
1.6
8.7
215
1387
UJF32
NOMESCO Finland
Coloscopy
1.6
8.7
257
1735
R06AX22
ATC
ebastine; oral
1.6
8.6
228
1497
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
8.6
205
1307
AA1AD
NOMESCO Finland
CT of head and brain
1.6
8.6
232
1530
B00.11
ICD-10 Finland
Herpes simplex labialis
4.7
8.6
28
61
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
8.6
82
376
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
8.3
8.6
18
22
B00.0
ICD-10 Finland
Eczema herpeticum
9.0
8.5
17
19
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
8.5
125
686
D07AB01
ATC
clobetasone; topical
2.9
8.5
49
170
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
8.5
699
5778
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.7
8.4
35
96
H02AB09
ATC
hydrocortisone; systemic
3.0
8.4
46
156
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
5.5
8.3
23
42
R03BA05
ATC
fluticasone; inhalant
1.5
8.3
268
1846
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.2
268
1847
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.0
8.2
98
495
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.1
417
3167
SPAT1229
SPAT
Assessment of need for aid
2.3
8.1
71
314
L02.1
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of neck
11.8
8.1
14
12
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.5
8.1
27
61
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.9
248
1695
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
7.9
131
751
R03BA01
ATC
beclometasone; inhalant
1.7
7.8
162
994
M54.5
ICD-10 Finland
Low back pain
1.4
7.7
412
3147
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.7
442
3420
L04AA01
ATC
[U] ciclosporin; systemic
4.1
7.7
28
69
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.1
7.7
28
69
B07.9
ICD-10 Finland
Verruca simplex
2.4
7.7
63
271
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
7.6
123
696
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
7.6
338
2491
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.6
406
3104
S10
ICPC
Boil/carbuncle
2.4
7.5
62
266
R03BB04
ATC
tiotropium bromide; inhalant
2.0
7.5
91
466
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
7.5
67
299
C03CA01
ATC
furosemide; systemic
1.6
7.5
204
1346
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
4.2
7.4
26
62
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.4
7.4
61
262
L30.8
ICD-10 Finland
Other specified dermatitis
3.2
7.3
36
114
L01CD
ICD-10 Finland
NA
+∞
7.3
7
*
N05CD07
ATC
temazepam; oral
1.9
7.3
107
586
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
7.3
162
1013
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.3
868
7535
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.2
154
954
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.5
7.2
31
89
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.2
582
4760
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.8
7.1
117
667
R03AC03
ATC
terbutaline; inhalant
1.6
7.1
176
1134
B02.9
ICD-10 Finland
Zoster without complication
2.3
7.0
59
257
ZX120
NOMESCO Finland
Intravenous
1.8
7.0
111
627
N02BE01
ATC
paracetamol; systemic, rectal
1.4
7.0
1151
10459
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
7.0
185
1214
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
6.9
108
604
A92
ICPC
Allergy/allergic reaction NOS
2.3
6.9
59
260
N05AX12
ATC
aripiprazole; systemic
2.1
6.9
73
354
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.8
6.8
109
616
R52.2
ICD-10 Finland
Other chronic pain
2.6
6.8
46
180
L73.2
ICD-10 Finland
Hidradenitis suppurativa
5.0
6.8
20
40
48609
ICD-8 Finland
Pneumonia, unspecified
3.5
6.8
29
83
F03
ICPC
Eye discharge
1.9
6.7
95
515
J01AA02
ATC
doxycycline; systemic
1.3
6.7
956
8470
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.8
6.7
26
69
L70.0
ICD-10 Finland
Acne vulgaris
2.1
6.6
69
332
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
6.6
86
451
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.6
109
623
J01XC01
ATC
fusidic acid; systemic
3.9
6.6
25
65
N03AX16
ATC
pregabalin; oral
1.5
6.6
242
1714
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
4.2
6.5
23
56
J01AA07
ATC
tetracycline; systemic
1.5
6.5
212
1463
D07AC14
ATC
methylprednisolone aceponate; topical
2.2
6.4
65
308
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.9
6.4
35
121
J20
ICD-10 Finland
Acute bronchitis
1.8
6.4
111
648
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.3
320
2409
03599
ICD-8 Finland
Erysipelas
8.2
6.3
13
16
J01FA06
ATC
roxithromycin; oral
1.3
6.3
471
3785
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.7
6.3
25
68
L20.8
ICD-10 Finland
Other atopic dermatitis
3.9
6.3
24
63
R95
ICPC
Chron obstructive pulmonary disease
3.9
6.3
24
63
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.1
6.3
31
100
Q82.81
ICD-10 Finland
Keratosis follicularis [Darier-White]
+∞
6.3
6
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
6.2
108
630
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.2
415
3276
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
6.2
93
516
N05BA04
ATC
oxazepam; oral
1.4
6.2
285
2109
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.5
6.2
47
194
N03AX12
ATC
gabapentin; oral
1.6
6.2
162
1062
SPAT1312
SPAT
General health counselling
1.3
6.1
479
3873
K04.08
ICD-10 Finland
Other specified pulpit
1.8
6.1
105
609
S19
ICPC
Skin injury other
2.4
6.1
48
204
N05AH03
ATC
olanzapine; systemic
1.8
6.1
92
512
A07EC02
ATC
mesalazine; oral, rectal
2.0
6.1
74
380
N06AB03
ATC
fluoxetine; oral
1.6
6.1
160
1049
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.7
6.1
37
137
K50.8
ICD-10 Finland
Other Crohn disease
3.3
6.1
28
86
N07BB01
ATC
disulfiram; oral
2.1
6.0
65
319
WX892
NOMESCO Finland
Monitored bed care
1.9
6.0
86
471
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
406
1497
3.22
84.02
2.1
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
479
2815
1.96
31.89
5.5
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
989
7392
1.76
29.21
9.8
6.6
e9/l
0.2
0.2
3.62
902
6519
(3006315) Basophils [#/volume] in Blood
959
7134
1.74
28.53
9.2
6.2
e9/l
0.0
0.0
1.76
859
6193
(3001604) Monocytes [#/volume] in Blood
956
7114
1.74
28.33
9.2
6.2
e9/l
0.6
0.6
3.45
859
6177
(3042936) Bacteria identified in Isolate by Culture
308
1606
2.11
28.25
2.1
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1053
8102
1.73
27.18
13.0
8.9
e9/l
4.1
3.9
1.69
941
7065
(40768443) Skin Pathology biopsy report
132
475
2.92
27.15
1.2
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
688
4719
1.74
26.87
9.1
6.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
906
6743
1.70
25.95
9.2
6.3
%
3.2
2.9
2.31
869
6341
(3019198) Lymphocytes [#/volume] in Blood
974
7398
1.70
25.78
9.3
6.2
e9/l
2.0
2.1
1.09
894
6573
(3024561) Albumin [Mass/volume] in Serum or Plasma
709
4956
1.71
25.52
6.1
5.0
g/l
36.2
36.7
1.44
656
4641
(3022096) Basophils/100 leukocytes in Blood
880
6523
1.69
25.40
9.3
6.4
%
0.7
0.7
0.47
842
6147
(3019069) Monocytes/100 leukocytes in Blood
907
6798
1.68
24.92
9.8
6.5
%
8.3
8.3
0.06
871
6440
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1204
9789
1.70
23.70
9.5
6.6
u/l
81.9
79.7
0.78
1143
9239
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
790
5854
1.63
21.64
9.2
6.9
mmol/l
1.2
1.2
0.19
672
5009
(3018010) Neutrophils/100 leukocytes in Blood
908
6980
1.61
21.25
8.9
6.1
%
55.8
55.3
0.68
871
6611
(3002030) Lymphocytes/100 leukocytes in Blood
919
7089
1.61
21.17
9.3
6.2
%
29.1
30.2
2.35
880
6698
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
302
1761
1.86
19.54
2.4
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
824
6316
1.57
18.63
7.7
5.8
umol/l
10.8
12.4
1.84
771
5948
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
61
174
3.59
18.38
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
161
769
2.20
18.16
1.8
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
713
5318
1.57
17.99
8.5
6.6
mmol/l
1.2
1.2
0.31
660
4886
(3013826) Glucose [Moles/volume] in Serum or Plasma
940
7460
1.55
17.93
5.9
4.7
mmol/l
6.6
6.4
1.51
871
6850
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
713
5432
1.52
15.74
2.9
2.4
nmol/l
73.1
73.2
0.04
653
5033
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
211
1172
1.91
15.70
5.1
4.6
u/l
261.6
251.6
0.13
201
1115
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
464
3222
1.59
15.48
3.1
2.2
mg/l
2.9
2.8
0.37
410
2795
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1587
14475
1.86
15.27
17.7
10.9
mg/l
21.4
21.3
0.01
1283
10957
(3013707) Erythrocyte sedimentation rate by Westergren method
1174
9965
1.52
15.09
5.0
3.7
mm/h
11.6
9.5
5.09
1093
9295
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
31
61
5.15
15.07
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
135
657
2.14
14.50
1.7
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
205
1165
1.86
14.17
1.7
1.3
u/ml
1827.5
234.4
3.96
197
1083
(3000494) Fungus identified in Specimen by Culture
245
1473
1.77
14.06
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
336
2202
1.65
14.04
1.8
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
201
1142
1.86
13.90
3.5
2.8
g/l
10.8
10.1
1.30
190
1055
(3023520) Reticulocytes [#/volume] in Blood
159
836
1.99
13.87
3.6
3.5
e9/l
63.0
68.8
1.33
121
614
(3012095) Magnesium [Moles/volume] in Serum or Plasma
294
1869
1.69
13.79
6.3
4.7
mmol/l
0.8
0.8
4.17
280
1771
(3026008) Bacteria identified in Urine by Culture
480
3435
1.54
13.79
3.0
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
271
1691
1.71
13.61
8.9
6.9
mmol/l
1.1
1.1
0.49
255
1592
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
523
3831
1.52
13.42
3.4
2.4
u/l
55.5
56.4
0.17
490
3567
(3028026) IgM [Mass/volume] in Serum or Plasma
165
892
1.94
13.27
2.4
1.7
g/l
1.5
1.4
0.25
158
831
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
100
449
2.30
13.08
2.2
1.6
g/l
0.2
0.2
0.80
90
426
(3002032) Base excess in Venous blood by calculation
211
1244
1.79
12.91
6.9
5.8
mmol/l
1.8
1.5
0.48
170
978
(3018418) pH of Serum or Plasma
457
3286
1.52
12.68
5.6
3.6
ph
7.4
7.4
0.67
89
626
(3031040) Bacteria [#/volume] in Urine by Automated count
1042
8797
1.44
12.52
5.0
3.8
e6/l
668.2
1175.2
0.23
13
106
(3037522) Nuclear Ab [Titer] in Serum
300
1979
1.62
12.07
1.5
1.3
titre
612.9
526.5
0.26
65
386
(3021447) Carbon dioxide [Partial pressure] in Venous blood
208
1245
1.76
12.06
7.1
5.8
kpa
5.9
5.8
0.74
199
1208
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
99
460
2.22
11.96
2.2
1.6
g/l
1.2
1.2
0.10
92
438
(3015377) Calcium [Moles/volume] in Serum or Plasma
519
3871
1.48
11.94
3.6
3.1
mmol/l
2.4
2.4
0.33
460
3480
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
203
1215
1.76
11.77
2.1
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
203
1216
1.76
11.73
4.8
3.8
%
1.6
1.6
0.58
184
1108
(3032080) INR in Blood by Coagulation assay
563
4281
1.46
11.69
8.3
7.0
inr
1.2
1.2
0.04
187
1356
(3011412) CD3 cells [#/volume] in Blood
49
165
3.03
11.42
2.7
2.6
e9/l
1.4
1.3
0.29
32
102
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
112
558
2.07
11.34
7.4
11.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
263
1705
1.64
11.31
1.8
1.7
nmol/l
1069.2
1168.8
0.95
207
1322
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
43
135
3.24
11.26
2.6
2.7
e9/l
0.2
0.2
0.10
38
112
(3019550) Sodium [Moles/volume] in Serum or Plasma
1526
14018
1.61
11.14
18.2
11.7
mmol/l
139.4
139.6
1.84
1491
13630
(3018677) aPTT in Platelet poor plasma by Coagulation assay
277
1827
1.61
11.10
3.6
3.2
s
29.8
29.7
0.09
266
1780
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
98
468
2.16
11.07
1.7
1.7
iu/ml
0.5
0.2
0.33
12
77
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
202
1229
1.73
11.04
2.2
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1530
14075
1.60
10.97
18.3
11.8
mmol/l
3.9
3.9
0.04
1489
13653
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
93
442
2.16
10.64
2.7
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
189
1141
1.73
10.61
3.5
2.8
g/l
0.2
0.2
0.03
174
1072
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
397
2.23
10.58
2.3
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
185
1113
1.74
10.51
18.8
17.2
inr
1.3
1.2
0.06
32
175
(3024354) Oxygen [Partial pressure] in Venous blood
182
1094
1.74
10.37
7.2
5.4
kpa
4.9
4.8
0.05
171
1061
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
42
137
3.12
10.35
2.7
2.7
e6/l
608.0
580.7
0.10
37
111
(1616796) Gas panel - Central venous blood
65
268
2.48
10.33
3.8
3.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
77
343
2.30
10.31
2.6
2.3
ug/l
299.5
412.9
0.34
70
318
(3000850) Epithelial cells [#/volume] in Urine
361
2570
1.51
10.24
3.4
2.5
e6/l
6.4
6.9
0.23
332
2257
(3000991) Gas panel - Venous blood
190
1162
1.71
10.17
9.1
8.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1085
9405
1.39
10.11
4.9
3.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
163
957
1.77
10.08
4.6
4.2
%
0.4
0.6
0.28
33
217
(3047181) Lactate [Moles/volume] in Blood
74
328
2.31
10.03
4.5
7.5
mmol/l
1.2
1.2
0.05
67
284
(3036481) Cortisol [Moles/volume] in Serum or Plasma
216
1373
1.65
10.00
2.9
2.1
nmol/l
323.3
366.1
2.48
206
1278
(3021589) Normoblasts [#/volume] in Blood
782
6434
1.38
9.97
12.9
8.6
e9/l
0.0
0.0
0.10
660
5229
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
175
1058
1.72
9.77
6.7
6.1
kpa
5.1
5.1
0.19
161
1002
(3003396) Base excess in Arterial blood by calculation
184
1128
1.70
9.76
6.8
8.5
mmol/l
1.3
0.9
0.66
151
878
(3017181) Myelocytes/100 leukocytes in Blood
173
1043
1.73
9.75
4.7
4.5
%
0.5
0.9
1.52
43
292
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
26
64
4.11
9.71
1.5
1.3
u/ml
25.7
15.7
—
7
12
(3007164) IgA [Mass/volume] in Serum or Plasma
460
3470
1.44
9.64
1.7
1.5
g/l
2.1
2.2
0.04
291
2145
(3026493) Urate [Moles/volume] in Serum or Plasma
405
2989
1.46
9.52
3.3
2.6
umol/l
335.9
4448.8
7.34
349
2676
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
28
74
3.83
9.51
5.4
4.5
mg/l
8.2
8.8
0.18
21
67
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1238
11024
1.40
9.48
4.2
3.8
pmol/l
14.4
14.5
0.82
1146
10178
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
170
1029
1.72
9.45
6.6
6.2
mmol/l
1.4
1.3
0.10
123
745
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
439
3294
1.44
9.44
2.5
2.1
u/l
165.0
246.7
1.36
417
3136
(3009343) pH of Capillary blood
173
1054
1.71
9.39
6.7
6.1
ph
7.4
7.4
0.42
18
89
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
558
4376
1.40
9.34
2.0
1.8
pmol/l
92.2
96.4
1.63
324
2416
(46235355) HIV 1 and 2 tests - Meaningful Use set
543
4241
1.40
9.30
2.1
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
441
3322
1.43
9.26
1.7
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
274
1882
1.54
9.12
3.0
2.4
umol/l
13.3
14.3
1.09
260
1759
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1610
15136
1.64
8.93
12.8
8.6
u/l
27.4
27.2
0.16
1575
14677
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
40
139
2.92
8.88
2.5
2.6
%
11.7
10.5
0.29
30
93
(3020779) Urea [Moles/volume] in Serum or Plasma
175
1086
1.68
8.87
12.3
9.1
mmol/l
7.7
7.5
0.21
170
1048
(3021879) Hepatitis B virus core Ab [Presence] in Serum
211
1376
1.60
8.79
1.6
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
164
1003
1.70
8.78
7.0
9.1
%
95.5
95.7
0.14
157
970
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
233
1556
1.57
8.77
3.1
2.5
%
21.9
24.0
1.07
196
1362
(40758558) Short blood count panel - Blood
459
3514
1.41
8.74
10.2
6.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
23
56
4.15
8.72
1.3
1.4
—
71.3
—
0
8
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
68
310
2.24
8.67
7.2
7.1
iu/ml
206.9
303.8
—
8
47
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
316
2264
1.48
8.56
1.7
1.6
pmol/l
33712576.4
30785442.4
0.03
264
1949
(3002582) Erythrocytes [#/volume] in Urine
491
3815
1.40
8.55
4.2
3.1
e6/l
45.1
84.3
0.76
399
2882
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1601
15061
1.60
8.48
18.3
11.8
umol/l
72.4
72.0
0.18
1601
15056
(3025159) Blasts/100 leukocytes in Blood
155
943
1.70
8.46
4.9
4.6
%
0.0
0.5
0.65
33
227
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
750
6242
1.35
8.44
4.7
3.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
195
2.56
8.43
4.2
3.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
164
1014
1.68
8.43
8.3
8.3
mmol/l
1.4
1.3
0.31
157
962
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
16
7.54
8.41
1.3
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
110
606
1.87
8.39
4.0
5.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
452
3473
1.40
8.37
4.0
3.0
e6/l
0.2
0.4
3.05
354
2564
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
221
1477
1.57
8.28
3.9
3.2
umol/l
6.9
7.2
0.07
185
1262
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
30
5.37
8.21
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
510
4011
1.38
8.19
3.5
3.0
ng/l
37.4
52.7
0.36
314
2250
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
23
59
3.94
8.16
1.3
1.5
—
322.0
—
0
5
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
95
504
1.93
8.13
4.7
4.5
g/l
3.5
3.3
0.44
86
480
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
170
1075
1.64
8.01
2.9
2.4
u/l
9365.7
4600.3
0.77
58
415
(3021960) Folate [Moles/volume] in Serum or Plasma
328
2396
1.45
8.01
1.6
1.4
nmol/l
20.1
20.1
0.01
286
2094
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
79
395
2.05
7.99
2.3
2.1
g/l
1.3
1.4
0.79
69
347
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
131
2.86
7.98
2.5
2.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
177
1134
1.62
7.92
7.0
8.4
kpa
5.1
5.1
0.05
168
1081
(3027801) Oxygen [Partial pressure] in Arterial blood
177
1134
1.62
7.92
6.9
8.4
kpa
12.1
12.9
1.49
167
1085
(3048689) Calprotectin [Mass/mass] in Stool
296
2125
1.47
7.90
3.7
2.6
ug/g
142.8
102.9
1.00
240
1700
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
570
4587
1.36
7.86
4.5
3.3
u/l
31.0
31.0
0.00
542
4363
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1373
12583
1.39
7.85
14.4
9.5
ml/min/173m2
92.1
90.9
1.09
1106
10094
(40760892) CBC W Ordered Manual Differential panel - Blood
437
3379
1.39
7.72
6.5
4.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
159
999
1.65
7.69
4.7
4.6
%
0.0
0.1
2.64
40
272
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
389
2952
1.41
7.67
2.7
2.1
mg/l
0.9
1.1
1.31
296
2143
(3020630) Protein [Mass/volume] in Serum or Plasma
126
744
1.75
7.66
3.1
2.5
g/l
67.6
67.3
0.23
117
691
(3014576) Chloride [Moles/volume] in Serum or Plasma
198
1317
1.57
7.57
8.2
7.5
mmol/l
104.5
104.6
0.13
192
1288
(3026782) Osmolality of Urine
328
2421
1.43
7.54
3.4
2.6
mosm/kgh2o
514.7
568.8
4.17
296
2081
(36304419) Bacteria [Presence] in Urine
445
3464
1.38
7.52
4.0
2.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
98
540
1.86
7.49
1.3
1.2
u/ml
0.2
1.5
1.26
11
41
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
69
337
2.09
7.45
2.1
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
244
1706
1.50
7.41
3.0
2.4
g/l
2.4
2.4
0.79
232
1588
(3010421) pH of Blood
63
299
2.15
7.32
5.0
3.3
ph
7.4
7.4
0.30
55
251
(3028626) Oxygen [Partial pressure] in Capillary blood
109
626
1.79
7.30
7.1
7.4
kpa
9.5
9.4
0.20
102
593
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
139
860
1.67
7.14
7.4
6.4
mmol/l
24.1
23.8
0.63
130
799
(3029937) Albumin [Presence] in Urine by Test strip
456
3589
1.36
7.14
4.2
3.4
estimate
0.0
0.0
1.08
176
1301
(3036489) Thrombin time
103
588
1.80
7.04
3.7
3.5
s
21.4
21.8
0.35
92
524
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
56
258
2.21
7.02
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
56
258
2.21
7.02
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
456
3604
1.36
6.92
4.4
3.3
mmol/l
7.9
8.4
1.27
408
3109
(3012501) Base excess in Blood by calculation
55
253
2.21
6.92
5.2
3.4
mmol/l
2.4
2.2
0.15
37
156
(3030905) Polymorphonuclear cells [#/volume] in Blood
59
280
2.14
6.88
4.0
3.4
e9/l
4.9
3.9
2.08
59
280
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
255
1834
1.46
6.70
3.0
2.7
mmol/l
2.4
2.4
0.89
213
1614
(3018095) Leukocytes [#/volume] in Urine
565
4629
1.32
6.68
4.7
3.6
e6/l
60.0
82.3
0.65
425
3115
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
491
3942
1.34
6.68
1.5
1.4
u/ml
1.4
1.8
0.48
123
999
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
60
290
2.11
6.68
4.5
3.7
%
60.1
55.4
1.87
60
290
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
327
2465
1.40
6.62
3.7
3.2
ng/l
1455.9
1020.7
0.74
278
2050
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
12
21
5.75
6.59
2.0
2.0
mg/l
1.6
1.8
—
7
16
(3011397) Hemoglobin [Presence] in Urine by Test strip
393
3059
1.36
6.54
3.6
3.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
26
85
3.09
6.47
37.4
33.3
ug/l
7.0
7.1
0.16
21
73
(3001122) Ferritin [Mass/volume] in Serum or Plasma
792
6813
1.29
6.47
3.4
2.8
ug/l
95.3
93.4
0.11
736
6390
(3044640) Blood type and Crossmatch panel - Blood
499
4040
1.33
6.36
2.9
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
170
1137
1.55
6.35
4.0
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
43
3.98
6.17
1.1
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1396
12980
1.34
6.14
5.1
4.3
mu/l
2.0
1.9
0.06
1309
12168
(3010375) cycloSPORINE [Mass/volume] in Blood
26
89
2.95
6.01
28.0
36.0
ug/l
114.2
141.9
0.88
21
77
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
127
807
1.62
5.91
6.8
6.5
mmol/l
24.5
24.5
0.04
122
783
(4062490)
37
154
2.43
5.89
1.4
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
136
2.53
5.88
2.6
2.3
e6/l
882.6
773.5
0.31
12
40
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
21
64
3.31
5.86
1.5
1.5
iu/ml
—
965700.0
—
0
5
(3004588) Protein electrophoresis panel - Serum or Plasma
97
576
1.72
5.84
3.2
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
391
3089
1.34
5.84
2.9
2.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
408
3250
1.33
5.75
5.8
4.2
%
91.1
92.6
0.60
400
3162
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
116
727
1.64
5.71
3.3
3.3
ng/l
102.6
159.2
2.10
105
650
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
234
2.12
5.68
2.3
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
128
825
1.59
5.63
1.3
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
19
56
3.42
5.59
1.4
1.2
g/l
0.3
0.3
0.31
13
48
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
172
1186
1.50
5.58
2.9
2.2
u/l
29.2
74.4
0.58
146
1009
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
21
5.26
5.52
1.5
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
36
153
2.38
5.49
1.4
1.2
g/l
7.3
6.5
0.62
26
114
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
153
2.38
5.49
1.4
1.2
g/l
2.3
2.7
0.84
26
112
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
153
2.38
5.49
1.4
1.2
g/l
0.6
0.4
0.44
26
113
(3022313) Gas panel - Capillary blood
129
838
1.58
5.49
7.0
6.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
96
583
1.68
5.35
1.9
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
784
6846
1.26
5.32
3.9
3.2
estimate
0.0
0.0
0.80
173
1290
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
90
538
1.71
5.32
8.7
10.7
mmol/l
24.7
24.3
0.67
84
512
(3028707) Methadone [Presence] in Urine by Screen method
82
478
1.75
5.29
5.2
2.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
74
3.00
5.26
2.2
2.7
u/ml
1215.3
930.1
0.29
22
74
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
102
2.67
5.25
1.9
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
102
2.67
5.25
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
102
2.67
5.25
1.9
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
57
298
1.94
5.20
7.0
4.9
mmol/l
24.0
24.4
0.25
51
268
(3019150) Specific gravity of Urine by Refractometry
371
2955
1.32
5.18
4.1
3.3
kg/l
1.0
1.0
0.32
58
421
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
299
1.94
5.15
3.1
8.1
u/ml
0.3
0.4
0.41
35
163
(3052851) Hemolysis interference index of Serum or Plasma
64
349
1.86
5.15
5.0
3.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
300
1.93
5.10
2.6
2.0
g/l
10.5
10.6
0.04
47
263
(3023183) Ammonium ion [Moles/volume] in Plasma
57
302
1.92
5.01
2.7
3.0
umol/l
32.6
34.2
0.27
50
272
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
269
2057
1.36
4.93
3.3
2.7
e6/l
1.0
1.0
0.03
162
1137
(3020717) Zinc [Moles/volume] in Serum or Plasma
25
94
2.68
4.92
1.5
1.7
umol/l
16.6
24.9
1.01
25
88
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
62
340
1.85
4.91
2.2
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1090
9938
1.25
4.86
3.9
3.0
u/l
46.7
41.2
1.13
1030
9487
(3000060) B lymphocytes [#/volume] in Blood
24
89
2.72
4.85
2.9
2.8
e6/l
365.0
324.4
0.12
18
55
(3035350) Ketones [Presence] in Urine by Test strip
772
6782
1.24
4.81
3.9
3.2
estimate
0.0
0.0
0.00
179
1288
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
244
1.99
4.76
1.7
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
118
779
1.55
4.72
4.6
2.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
47
238
2.00
4.72
1.7
1.6
g/l
0.9
0.7
0.21
34
184
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
54
288
1.90
4.67
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
772
6797
1.24
4.67
5.2
4.4
estimate
0.0
0.0
0.50
176
1337
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
298
2335
1.33
4.64
1.3
1.2
iu/ml
19.3
26.0
1.20
81
702
(3026361) Erythrocytes [#/volume] in Blood
1706
16581
1.64
4.55
25.5
16.0
e12/l
4.5
4.6
6.38
1665
16131
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
21
4.78
4.53
1.5
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
10
21
4.78
4.53
1.2
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
373
3027
1.29
4.49
2.4
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
270
2095
1.34
4.49
4.4
3.3
ng/l
201.1
642.7
3.22
170
1382
(40767503) Oxygen content in Capillary blood by calculation
45
229
1.99
4.47
2.3
2.3
%
16.7
17.1
0.29
28
114
(3034860) Kappa light chains.free [Mass/volume] in Serum
46
236
1.97
4.47
3.9
3.5
mg/l
78.6
75.1
0.03
39
185
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
46
236
1.97
4.47
3.9
3.5
mg/l
28.5
30.6
0.18
38
186
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
283
2213
1.33
4.46
1.9
1.7
%
1.5
1.4
1.56
244
1987
(3024731) MCV [Entitic volume]
1705
16576
1.62
4.45
25.5
15.9
fl
89.9
89.7
1.12
1693
16380
(3035941) MCH [Entitic mass]
1705
16578
1.62
4.42
25.4
15.9
pg
30.0
30.0
0.09
1694
16381
(3020191) Ethanol [Moles/volume] in Serum or Plasma
29
124
2.36
4.42
2.8
1.4
promille
1.8
1.2
0.95
23
100
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
281
2200
1.33
4.39
1.3
1.2
u/ml
5.5
10.2
1.10
103
914
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
611
5274
1.24
4.36
4.0
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
318
1.82
4.32
2.1
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1705
16586
1.61
4.31
25.6
16.0
e9/l
7.0
6.7
3.17
1665
16123
(3000963) Hemoglobin [Mass/volume] in Blood
1705
16592
1.60
4.23
25.7
16.1
g/l
135.1
136.9
6.06
1692
16393
(3014599) Egg white IgE Ab [Units/volume] in Serum
37
179
2.09
4.22
1.4
1.2
u/ml
2.5
4.7
0.41
22
78
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1253
11680
1.24
4.22
5.0
4.5
mmol/mol
39.0
38.2
1.71
1169
11020
(3007461) Platelets [#/volume] in Blood
1702
16560
1.58
4.17
25.6
16.0
e9/l
262.8
257.4
2.56
1672
16128
(3020874) Milk IgE Ab [Units/volume] in Serum
37
180
2.08
4.17
1.4
1.3
u/ml
4.4
2.7
0.20
24
89
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
23
91
2.55
4.13
1.5
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
117
796
1.50
4.10
1.8
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
86
2.58
4.05
7.0
3.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
325
1.78
4.04
2.6
2.0
g/l
7.1
7.3
0.34
42
258
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
325
1.78
4.04
2.6
2.0
g/l
4.6
3.8
0.84
42
245
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
325
1.78
4.04
2.6
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
61
355
1.74
4.03
1.5
1.4
ug/g
283.4
315.0
0.49
31
194
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
124
858
1.48
4.01
4.4
3.2
mmol/l
1.2
1.2
0.03
112
741
(3010726) Horse dander IgE Ab [Units/volume] in Serum
80
502
1.62
4.00
1.2
1.1
u/ml
2.2
2.6
0.22
35
148
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
131
2.23
3.93
2.1
1.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
24
4.18
3.89
3.1
3.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
10
24
4.18
3.89
1.1
1.0
u/ml
0.0
0.0
—
5
15
(3012494) Peanut IgE Ab [Units/volume] in Serum
27
119
2.29
3.88
1.3
1.2
u/ml
19.3
8.0
0.27
22
86
(1001926) Buprenorphine [Presence] in Urine by Screen method
130
915
1.45
3.87
3.9
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
482
4102
1.24
3.84
1.9
1.7
—
—
—
0
0
(4035726)
135
959
1.44
3.83
1.7
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
95
2.44
3.81
3.7
2.8
%
65.9
54.9
—
10
70
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
147
2.13
3.75
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
213
1640
1.34
3.73
1.3
1.2
—
—
—
0
0
(4010399)
118
822
1.47
3.71
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
86
560
1.56
3.71
1.2
1.2
u/ml
4.3
2.7
0.33
60
288
(3045142) Bone marrow Pathology biopsy report
28
129
2.19
3.64
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
31
149
2.10
3.64
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
48
269
1.81
3.63
1.2
1.3
u/ml
0.9
4.9
—
5
23
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
150
2.09
3.58
1.4
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
119
837
1.45
3.57
5.7
5.0
ng/l
72.4
73.7
0.07
104
766
(3014148) Varicella zoster virus Ab [Titer] in Serum
49
278
1.78
3.57
1.3
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
9
7.80
3.56
6.1
9.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
137
2.14
3.56
4.1
3.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
30
144
2.10
3.54
1.4
1.5
pmol/l
276.8
354.7
0.98
22
117
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
48
272
1.79
3.51
1.4
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
249
1978
1.30
3.50
3.6
2.9
e6/l
2.5
2.6
0.13
137
1062
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
200
1.92
3.49
2.1
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
27
125
2.18
3.48
1.6
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
303
1.74
3.47
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
166
2.01
3.45
2.3
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
88
587
1.52
3.43
1.8
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
94
637
1.50
3.41
8.7
10.2
%
93.3
94.0
0.30
94
632
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
60
366
1.66
3.40
1.9
2.0
ug/l
3.2
1.9
0.27
46
327
(21494890) Protein electrophoresis panel - 24 hour Urine
20
82
2.46
3.38
2.1
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
319
2629
1.26
3.35
1.8
1.8
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
12
37
3.26
3.34
1.0
1.1
u/ml
1.2
3.6
—
7
26
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
71
2.55
3.29
2.0
2.1
umol/l
329.1
170.0
—
10
37
(3044290) Cell count panel - Cerebral spinal fluid
52
308
1.71
3.29
2.9
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1584
15298
1.31
3.28
15.5
10.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
96
2.31
3.27
2.5
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
309
1.70
3.25
2.8
2.0
g/l
2.9
3.1
0.71
42
249
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
54
2.79
3.25
2.5
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
54
2.79
3.25
2.5
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
54
2.79
3.25
2.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
54
2.79
3.25
2.5
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
40
220
1.84
3.24
1.7
1.6
—
—
—
0
0
(44813793)
26
123
2.13
3.20
1.1
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
28
3.59
3.19
1.2
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
34
179
1.92
3.15
3.4
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
353
2970
1.23
3.07
4.4
4.0
mg/mmol
58.0
9.4
0.54
243
1969
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
17
68
2.51
3.04
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
147
1.99
3.00
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
147
1.99
3.00
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
61
387
1.60
2.99
3.6
4.7
—
—
—
0
0
(3013512) EKG study
357
3018
1.23
2.96
3.3
3.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
57
2.65
2.96
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
29
148
1.98
2.95
1.4
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1344
12787
1.21
2.93
4.0
3.6
mmol/l
5.8
5.7
1.36
1233
11892
(3003888) Timothy IgE Ab [Units/volume] in Serum
77
518
1.51
2.93
1.2
1.1
u/ml
5.7
6.1
0.07
61
322
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
203
1609
1.30
2.92
2.2
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
33
177
1.88
2.92
1.7
1.5
—
—
—
0
0
(44790049)
37
206
1.81
2.92
1.5
1.8
—
—
—
0
0
(44790047)
37
206
1.81
2.92
1.5
1.8
—
—
—
0
0
(44790048)
37
206
1.81
2.92
1.5
1.8
—
—
—
0
0
(44806118)
37
206
1.81
2.92
1.5
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
30
156
1.94
2.90
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
73
487
1.52
2.89
4.4
4.6
g/l
0.3
0.2
0.20
44
249
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
125
924
1.38
2.89
3.0
2.3
ml/min/173m2
69.1
75.3
0.89
48
340
(3016879) Cocaine [Presence] in Urine
144
1089
1.35
2.88
3.8
1.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
336
1.63
2.88
2.9
1.9
e6/l
133.1
1692.6
1.05
47
269
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
336
1.63
2.88
2.9
1.9
e6/l
7.3
10.8
0.30
44
259
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
102
2.17
2.87
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
102
2.17
2.87
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
379
3237
1.22
2.84
1.8
1.6
mmol/l
1.4
1.4
0.47
335
2821
(3019225) pH of Specimen
134
1005
1.36
2.83
4.4
3.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
337
2847
1.23
2.81
3.6
3.3
mg/l
762.4
314.3
0.74
243
1894
(36660697) Celiac disease serology panel - Serum
182
1430
1.30
2.80
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
65
2.47
2.79
1.6
2.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
65
2.47
2.79
1.6
2.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
23
3.93
2.77
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
166
1.88
2.77
2.1
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
106
768
1.40
2.76
2.7
2.2
ug/l
6.6
8.1
0.22
90
684
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
67
444
1.53
2.75
2.0
1.5
u/ml
229.5
242.3
0.10
35
261
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
42
2.87
2.75
3.2
2.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
130
1708
0.74
2.74
1.5
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
69
461
1.52
2.73
1.9
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
24
118
2.05
2.72
8.0
3.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
908
1.37
2.72
3.9
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
160
1.89
2.71
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
153
1179
1.33
2.71
3.7
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
154
1188
1.32
2.71
3.7
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
28
146
1.93
2.70
1.8
1.5
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
14
54
2.61
2.70
3.1
5.3
g/mol
3142.3
57.3
0.47
14
47
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
60
2.51
2.70
1.0
1.4
%
73.8
92.8
—
6
33
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
60
390
1.56
2.69
1.8
1.7
—
11.2
—
0
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
164
1278
1.31
2.69
6.6
5.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
154
1190
1.32
2.68
3.7
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
23
112
2.07
2.67
2.9
3.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
250
1.70
2.66
1.4
1.2
u/ml
1.8
5.4
1.97
20
106
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
154
1.90
2.66
2.4
1.9
—
—
—
0
0
(4306422)
40
236
1.71
2.62
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
49
2.67
2.62
1.2
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
15
61
2.47
2.62
1.0
1.1
%
81.2
94.1
—
6
34
(3032057) Clostridioides difficile [Presence] in Stool
7
15
4.68
2.59
1.6
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
64
427
1.52
2.57
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
159
1243
1.31
2.56
4.7
3.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
31
171
1.83
2.55
2.3
1.6
mmol/l
58.8
73.2
0.95
26
145
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
44
2.74
2.54
1.3
1.2
ug/l
8.0
8.7
0.28
12
44
(3000093) Morphology [Interpretation] in Blood Narrative
22
108
2.05
2.52
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
63
421
1.51
2.51
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
39
2.83
2.47
6.4
10.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
33
188
1.77
2.46
1.6
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
163
2044
0.78
2.45
1.3
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
73
506
1.46
2.45
1.2
1.1
u/ml
1.8
1.0
0.33
55
268
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
196
1.75
2.43
2.4
1.6
—
—
—
0
0
(4268621)
30
167
1.81
2.41
2.5
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
47
297
1.60
2.40
3.0
2.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
27
3.34
2.39
4.2
5.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
418
1.50
2.39
1.2
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
28
153
1.84
2.39
1.3
1.1
u/ml
0.6
3.0
—
10
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
382
3318
1.19
2.38
2.5
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
251
1.65
2.38
1.4
1.2
u/ml
1.5
2.9
0.82
11
85
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
64
435
1.49
2.37
1.9
2.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
5
8
6.26
2.37
1.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
104
2.03
2.36
1.3
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
58
387
1.52
2.35
1.9
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
84
2.15
2.35
2.9
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
169
1349
1.28
2.34
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
113
856
1.34
2.29
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
149
1175
1.29
2.27
3.5
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
52
342
1.54
2.26
1.3
1.3
u/ml
1.5
2.6
—
8
38
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
106
1.99
2.25
1.2
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
30
171
1.77
2.25
4.4
3.5
%
1.2
1.2
0.03
20
144
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
29
3.11
2.22
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
21
107
1.97
2.20
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
24
3.34
2.18
1.8
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
108
1.96
2.15
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
30
174
1.74
2.14
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
251
1.61
2.13
1.9
2.3
g/l
129.7
134.4
0.57
34
192
(3037756) Immunofixation for Serum or Plasma
29
167
1.75
2.12
2.0
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
88
2.06
2.11
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1329
12752
1.16
2.11
21.4
13.5
%
13.6
13.4
2.45
1320
12487
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
52
348
1.51
2.11
1.3
1.3
u/ml
2.6
12.1
1.49
11
59
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
236
1984
1.22
2.08
2.4
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
82
2.08
2.07
1.1
1.1
miu/ml
1743.5
1637.5
0.12
17
82
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
82
2.08
2.07
1.8
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
21
110
1.92
2.06
1.4
1.1
u/l
105.2
92.2
0.11
16
74
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
97
1.97
2.00
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
264
1.57
1.98
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
35
217
1.63
1.98
1.2
1.3
—
32.0
—
0
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
55
379
1.47
1.96
1.4
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
11
4.55
1.94
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
27
2.97
1.93
2.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
40
258
1.56
1.93
7.4
7.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
558
5070
1.15
1.93
2.2
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
37
235
1.59
1.91
1.5
1.7
e6/l
9591.0
10608.7
0.06
29
175
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
54
373
1.46
1.90
1.9
1.7
u/ml
113.1
99.2
—
9
59
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
158
1.72
1.89
2.5
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
143
1.76
1.89
2.4
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
121
1.83
1.88
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
65
2.16
1.88
1.0
1.0
iu/ml
167.9
251.2
0.61
14
65
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
49
333
1.48
1.88
2.4
1.7
mmol/l
3.5
3.7
1.34
44
315
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
34
2.66
1.86
1.9
1.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
107
1.88
1.86
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
107
1.88
1.86
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
107
1.88
1.86
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
107
1.88
1.86
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
93
1.94
1.85
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
93
1.94
1.85
9.9
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
66
477
1.40
1.84
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
75
554
1.37
1.83
1.5
2.0
u/l
39.0
39.2
0.03
67
515
(44816559) Phosphatidylethanol [Mass/volume] in Blood
50
343
1.47
1.83
1.4
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
40
2.51
1.83
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
230
1.58
1.82
2.3
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
127
1013
1.27
1.82
1.7
1.5
iu/l
20.1
23.1
0.51
101
824
(21494434) Karyotype in Bone marrow
20
108
1.86
1.82
1.6
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
89
677
1.33
1.81
2.0
1.5
u/l
9.6
8.3
0.36
67
522
(3020393) Adenovirus Ag [Presence] in Stool
12
53
2.27
1.80
1.3
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
271
1.52
1.80
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
30
184
1.64
1.79
1.1
1.1
—
—
—
0
0
(4198724)
20
109
1.84
1.77
2.2
1.8
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
10
41
2.45
1.75
1.0
1.0
u/ml
1.0
0.2
—
5
24
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
18
3.34
1.74
1.8
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
76
568
1.35
1.74
1.4
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
30
2.67
1.72
1.4
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
194
1.61
1.72
2.3
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
13
3.85
1.71
4.6
2.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
48
2.30
1.70
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
75
2.01
1.69
3.1
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
145
1187
1.24
1.68
2.1
2.1
nmol/l
11.5
12.7
1.03
129
1063
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
31
2.59
1.66
1.8
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
31
2.59
1.66
1.8
2.8
—
—
—
0
0
(3024471) HLA-A [Type]
13
62
2.10
1.65
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
49
2.25
1.63
1.4
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
14
3.58
1.61
1.6
1.6
—
—
—
0
0
(4038314)
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
14
3.58
1.61
1.8
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
143
1.69
1.61
1.7
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
198
1.58
1.60
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
503
5488
0.88
1.58
2.5
2.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
12
57
2.11
1.55
1.6
1.1
u/l
42.9
13.6
0.91
12
48
(3042733) HLA Ab [Presence] in Serum
13
64
2.04
1.54
5.5
4.4
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
14
71
1.98
1.54
1.0
1.1
%
91.9
91.7
—
8
59
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
33
2.43
1.53
1.0
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
22
130
1.70
1.53
1.2
1.3
umol/l
3.3
5.2
2.30
22
120
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
15
3.34
1.52
1.6
3.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
169
1.61
1.52
4.2
2.4
—
—
—
0
0
(4034850)
54
392
1.39
1.51
9.0
7.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
108
1.77
1.50
1.6
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1377
13351
1.14
1.50
21.7
13.6
g/l
333.4
333.7
0.60
1365
13230
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
35
234
1.51
1.50
1.1
1.2
%
106.3
111.9
0.46
29
217
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
96
1201
0.79
1.49
1.3
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
58
2.08
1.49
1.3
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
17
94
1.82
1.47
1.3
1.2
—
40.7
—
0
6
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
94
1.82
1.47
2.2
2.7
%
40.7
43.1
—
10
28
(3016018) Differential panel - Cerebral spinal fluid
25
155
1.62
1.47
3.3
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
77
594
1.31
1.47
1.5
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
132
1.67
1.46
1.1
1.3
u/ml
0.9
0.4
—
10
44
(3021788) Differential panel - Synovial fluid
28
179
1.57
1.46
1.5
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
16
3.13
1.44
2.6
3.5
u/l
21.2
1588.6
—
5
16
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
12
59
2.04
1.43
1.6
1.1
u/l
112.3
88.9
0.28
12
51
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
22
2.73
1.43
3.3
4.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1375
13343
1.13
1.43
4.0
3.7
mmol/l
4.6
4.7
1.63
1298
12634
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
39
2.31
1.43
2.4
2.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
40
2.26
1.40
2.0
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
40
2.26
1.40
1.3
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
78
992
0.78
1.40
1.4
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
49
356
1.39
1.38
1.2
1.1
u/ml
11.1
4.9
1.43
37
171
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
142
1.63
1.38
1.1
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
12
60
2.01
1.38
1.2
3.0
mmol/l
1.8
2.3
—
7
46
(3009542) Hematocrit [Volume Fraction] of Blood
1467
14306
1.14
1.37
18.3
11.8
%
40.1
40.4
1.00
1145
11649
(3017509) Phencyclidine [Presence] in Urine
6
23
2.61
1.36
2.3
1.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
5
17
2.95
1.36
1.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
47
2.13
1.33
1.1
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
47
2.13
1.33
2.6
2.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
48
351
1.38
1.32
2.9
2.7
umol/l
8.1
6.2
0.25
36
270
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
160
1.57
1.31
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
119
985
1.22
1.29
2.3
2.3
au/ml
52.2
22.8
—
6
73
(3014271) Vancomycin [Susceptibility]
8
34
2.36
1.29
2.4
2.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
110
904
1.23
1.28
1.3
1.2
au/ml
23.5
37.8
—
5
41
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
2.2
4.7
umol/l
38.0
45.7
—
5
12
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
114
1.67
1.28
1.5
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
62
1.94
1.27
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
55
2.01
1.27
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
135
0.44
1.27
1.2
1.4
nmol/l
30.4
31.7
—
6
115
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
115
1.66
1.25
1.5
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1314
12753
1.11
1.24
3.6
3.3
mmol/l
1.3
1.3
1.94
1236
12011
(3033799) Differential panel - Peritoneal fluid
6
25
2.40
1.24
1.7
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
139
1.59
1.23
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
63
1.91
1.22
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
108
1.67
1.22
2.3
2.5
pg
30.2
32.8
1.11
18
108
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
49
2.05
1.22
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
49
2.05
1.22
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
65
505
1.30
1.22
2.3
2.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
148
1.56
1.20
1.0
1.1
iu/ml
14.6
6.1
—
5
32
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
26
2.31
1.18
5.3
6.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
26
2.31
1.18
5.5
6.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
43
578
0.74
1.18
1.5
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
57
1.94
1.17
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
33
0.00
1.16
0.0
2.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
39
2.06
1.15
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
42
562
0.74
1.13
1.4
1.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
105
875
1.21
1.10
1.8
1.6
mu/l
376.2
306.8
1.13
93
785
(3014133) Dog dander IgE Ab [Units/volume] in Serum
51
390
1.32
1.09
1.2
1.1
u/ml
5.8
5.1
0.11
37
171
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
103
860
1.21
1.07
3.7
4.3
ug/l
24.7
25.6
0.02
82
673
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
24
161
1.50
1.07
2.4
4.2
u/ml
38.1
124.6
—
7
45
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
33
2.13
1.05
3.9
6.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
566
0.75
1.05
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1379
13460
1.11
1.05
4.2
3.9
mmol/l
2.8
2.8
1.04
1292
12655
(3041096) Erythrocytes [Presence] in Urine by Automated
425
3933
1.11
1.04
3.6
2.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
149
0.53
1.03
1.8
1.6
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
22
2.28
1.03
8.2
8.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
255
1.38
1.03
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
34
2.06
1.03
2.4
3.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
114
1.58
1.02
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
9
47
1.92
1.02
1.6
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
53
1.89
1.01
1.9
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
35
2.00
1.00
2.9
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
113
960
1.19
0.99
3.8
2.3
e9/l
4.1
4.1
0.08
84
817
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
23
2.18
0.98
1.0
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
132
1.52
0.97
1.1
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
54
1.86
0.96
4.1
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
54
1.86
0.96
4.1
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
199
1.41
0.95
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
52
1.73
0.92
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
34
252
1.36
0.92
1.5
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
24
167
1.44
0.92
1.3
1.3
nmol/l
0.6
0.6
0.16
24
159
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
122
1052
1.17
0.91
1.1
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
29
2.07
0.89
1.5
1.3
%
36.8
56.8
—
6
24
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
22
152
1.45
0.88
1.2
1.1
mg/l
27.9
37.1
1.10
17
117
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
39
298
1.32
0.88
1.2
1.2
u/ml
21.3
37.3
—
7
26
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
10
56
1.79
0.87
1.1
1.1
—
542.9
—
0
8
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
195
1.39
0.86
6.6
2.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
64
1.72
0.86
3.8
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
44
1.82
0.86
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
64
524
1.23
0.84
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
45
1.78
0.84
3.8
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
45
1.78
0.84
3.8
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
62
507
1.23
0.83
1.1
1.1
u/ml
10.5
5.1
—
7
81
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
115
0.52
0.82
1.0
1.5
g/l
0.9
1.0
—
6
115
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
46
1.74
0.82
3.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1355
13266
1.09
0.82
3.9
3.6
mmol/l
1.4
1.4
2.44
1268
12504
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
43
337
1.28
0.82
4.3
3.5
u/ml
123.3
1230.4
1.24
38
288
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
43
337
1.28
0.82
1.1
1.1
u/ml
1.0
0.5
0.44
25
108
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
8
47
1.71
0.80
3.5
2.0
—
145.2
—
0
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
48
1.67
0.78
4.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
894
8626
1.07
0.78
3.4
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
165
1.40
0.77
2.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
168
1871
0.89
0.77
2.8
2.7
ug/l
0.6
0.7
0.75
96
1082
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
270
2488
1.10
0.74
1.6
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
54
1.67
0.74
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
54
1.67
0.74
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
138
1224
1.14
0.74
1.3
1.2
iu/ml
152.7
142.2
0.10
50
476
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
24
176
1.37
0.72
1.1
1.1
%
90.3
92.5
0.13
24
167
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
159
1.39
0.72
1.3
1.5
mmol/l
11.7
11.8
—
6
30
(3022621) pH of Urine by Test strip
95
823
1.16
0.71
2.1
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
87
750
1.17
0.70
1.3
1.3
miu/ml
172.8
233.7
1.36
47
380
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
59
1.53
0.68
3.2
4.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
161
1.37
0.68
1.3
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
57
681
0.83
0.68
1.4
1.7
mg/l
6.3
3.6
1.05
42
452
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
149
1338
1.12
0.67
3.0
3.7
%
30.2
31.5
0.64
92
963
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
103
903
1.15
0.67
4.5
3.4
pmol/l
4.6
4.7
0.53
96
811
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
136
1.40
0.67
1.1
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
237
0.71
0.66
2.2
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
31
241
1.29
0.66
2.7
2.4
ug/min
226.2
97.5
0.29
20
152
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
11
70
1.57
0.65
1.5
1.6
nmol/l
13.7
4.6
0.30
11
57
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
70
1.57
0.65
1.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
7
44
1.59
0.65
3.4
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
65
762
0.85
0.64
1.5
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
168
1528
1.11
0.62
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
50
1.60
0.61
3.4
2.9
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.3
—
9.6
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
52
1.54
0.59
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
44
363
1.22
0.59
1.6
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
86
753
1.15
0.59
2.4
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
18
131
1.38
0.59
16.1
14.2
nmol/l
920.6
772.8
0.56
18
125
(3003694) ABO and Rh group [Type] in Blood
483
4605
1.07
0.59
1.6
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
391
1.21
0.58
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
57
669
0.85
0.58
1.1
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
106
1.42
0.57
1.5
1.5
mmol/l
1.6
1.8
1.59
15
101
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
211
1.28
0.57
1.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
274
1.25
0.57
1.3
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
10
65
1.54
0.55
4.5
2.4
mg/l
8.3
10.3
—
10
53
(3006653) Thiamine [Moles/volume] in Blood
10
65
1.54
0.55
1.2
1.4
nmol/l
162.0
141.7
—
10
65
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1219
11966
1.06
0.53
3.9
3.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
91
1.43
0.53
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
63
1.43
0.52
1.4
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
100
1.40
0.51
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
83
1.45
0.51
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
126
1.35
0.51
1.4
1.5
umol/l
12.0
11.3
0.16
17
117
(3012441) Differential panel - Pleural fluid
11
75
1.47
0.50
1.4
1.3
—
—
—
0
0
(4027681)
17
127
1.34
0.49
1.5
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
45
1.56
0.49
3.7
2.8
ug/l
156.6
105.2
—
7
45
(3015183) Erythrocyte sedimentation rate
7
107
0.65
0.48
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
226
1.24
0.48
3.0
2.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
47
1.49
0.47
4.4
3.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
39
327
1.20
0.47
1.5
1.5
nmol/l
0.4
0.3
0.13
34
263
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
102
1.38
0.47
1.1
1.2
u/ml
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
273
1.21
0.46
1.5
1.1
iu/ml
315591.1
1784.9
—
7
74
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
2.4
2.3
umol/l
15.5
19.7
—
7
50
(3032773) Endomysium IgG Ab [Titer] in Serum
25
201
1.25
0.45
1.2
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
40
339
1.18
0.44
4.1
4.0
mmol/l
1.5
1.4
0.11
40
331
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
95
1.37
0.43
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
274
0.80
0.43
1.3
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
34
285
1.20
0.42
1.5
1.4
u/l
16.4
20.1
0.38
28
236
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
52.0
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
62
699
0.88
0.41
1.5
1.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
62
698
0.88
0.40
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
62
698
0.88
0.40
1.5
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
60
1.33
0.40
1.1
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
61
1.31
0.39
1.1
1.2
u/l
163.9
433.1
—
8
56
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
3.2
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
62
696
0.89
0.39
1.5
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
115
1.31
0.39
1.2
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
72
647
1.12
0.38
1.7
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
98
1.33
0.37
2.8
2.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
158
0.76
0.37
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
70
1.29
0.36
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
180
1693
1.07
0.36
1.7
1.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
9
71
1.27
0.36
1.3
1.6
u/field
1.0
4.2
—
9
58
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
20
162
1.24
0.35
4.1
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
80
0.62
0.35
1.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
47
532
0.88
0.35
1.7
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
44
1.36
0.34
1.3
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
20
163
1.23
0.34
3.9
3.4
u/ml
45.2
24.4
0.75
20
158
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
275
0.83
0.33
3.3
3.3
mg/l
18.8
23.6
0.50
13
169
(4094501)
26
304
0.85
0.30
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
129
1.24
0.30
1.6
2.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
111
1.26
0.30
1.1
1.0
u/l
1.1
1.0
—
7
53
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
102
1.28
0.30
1.2
1.4
nmol/l
1.0
1.5
1.73
13
93
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
303
0.86
0.29
1.0
1.1
u/ml
3.8
2.1
—
10
146
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
157
1.21
0.29
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
525
1.11
0.29
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
27
232
1.17
0.28
3.5
3.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
106
990
1.08
0.28
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
60
547
1.10
0.27
2.9
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
96
901
1.07
0.23
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
222
0.85
0.23
1.4
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
4.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
43
1.16
0.21
2.6
6.8
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
43.9
—
0
5
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.5
—
321.1
—
0
13
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
13
0.00
0.21
0.0
1.0
—
159.8
—
0
13
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
272
0.88
0.21
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
135
1412
0.95
0.20
1.5
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
51
1.18
0.19
1.0
1.1
u/ml
16.1
41.4
—
6
51
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
81
764
1.06
0.19
1.7
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
24
213
1.13
0.18
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
24
269
0.89
0.18
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
323
3151
1.03
0.18
3.7
4.0
ug/l
2.2
2.1
0.12
290
2873
(3029396) Erythrocyte agglutination [Presence] in Blood
7
59
1.19
0.18
2.1
3.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
66
702
0.94
0.17
1.5
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
37
339
1.09
0.17
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
43
397
1.09
0.17
2.3
1.9
iu/l
2.8
5.2
3.00
18
149
(3008898) HLA-B27 [Presence]
62
659
0.94
0.16
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
292
1.10
0.16
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
139
1.15
0.16
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
2.2
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
111
1.17
0.15
12.1
12.1
%
11.9
11.6
0.06
13
111
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
172
0.87
0.15
1.3
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
130
1.16
0.15
5.5
3.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
322
1.09
0.15
2.3
2.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
12
102
1.18
0.15
1.8
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
59
556
1.06
0.15
1.6
1.7
—
—
—
0
0
(4024509)
9
83
1.08
0.14
1.3
1.3
—
—
—
0
0
(4146454)
7
86
0.81
0.14
2.4
2.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
86
1.16
0.11
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
145
1488
0.97
0.10
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
176
0.91
0.09
1.4
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
57
593
0.96
0.08
1.6
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
253
1.07
0.08
1.6
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
2.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.2
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
58
1.03
0.08
1.5
1.4
—
9.6
—
0
6
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
318
0.94
0.08
2.9
2.0
nmol/l
0.6
0.8
0.88
24
276
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
98
1.12
0.07
1.3
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
57
591
0.96
0.07
1.5
1.5
—
—
—
0
0
(4281824)
12
108
1.11
0.07
1.3
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
80
0.87
0.07
4.7
7.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
29
306
0.95
0.07
1.8
1.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
102
0.88
0.06
1.2
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
23
217
1.06
0.06
1.3
1.4
mmol/l
6.4
6.8
0.31
17
151
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
344
0.96
0.05
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
151
1.06
0.03
1.3
1.3
nmol/l
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
250
2516
0.99
0.02
3.5
3.5
%
21.2
20.9
0.09
86
1012
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
266
2675
0.99
0.02
1.5
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
35
359
0.97
0.02
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
35
358
0.98
0.01
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
60
607
0.99
0.01
1.5
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
96
1.04
0.00
4.1
4.6
ug/l
1.2
1.6
—
10
91
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
104
0.96
0.00
2.8
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
176
1.02
0.00
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
295
1.02
0.00
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
130
1.00
0.00
1.2
1.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
102
0.98
0.00
1.1
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
139
1.01
0.00
1.2
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
10
101
0.99
0.00
1.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4211845)
6
64
0.94
0.00
3.0
2.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.9
—
7.4
—
0
7
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
70
1.00
0.00
1.1
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.5
—
16.1
—
0
6
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
73
0.96
0.00
3.3
2.2
umol/l
44.1
48.4
—
7
61
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
59
1.02
0.00
1.7
1.7
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.6
—
0
6
(40768446) Kidney Pathology biopsy report
7
73
0.96
0.00
2.4
2.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.7
—
0
5
(3006462) Nitrate [Presence] in Urine
6
59
1.02
0.00
3.0
2.4
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
118.9
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.5
—
424.0
—
0
6
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
87
0.92
0.00
2.3
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_IMPETIGO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_IMPETIGO | 2.412 [1.88, 3.09] | < 0.001 |
| Birth year | 0.995 [0.98, 1.0] | 0.296 |
During the follow-up period (1.1.1998 — 31.12.2019), 434 out of 8762 females with L12_IMPETIGO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_IMPETIGO | 2.621 [2.05, 3.35] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.068 |
During the follow-up period (1.1.1998 — 31.12.2019), 538 out of 9066 males with L12_IMPETIGO died.
Mortality risk
Mortality risk for people of age
years, who have L12_IMPETIGO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.191% | 0.601% |
| 5 | 1.282% | 3.415% |
| 10 | 3.315% | 8.425% |
| 15 | 6.262% | 15.572% |
| 20 | 11.018% | 26.219% |
Relationships between endpoints
↥Index endpoint: L12_IMPETIGO – Impetigo
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data